 Hematopoietic Cell Growth Factors
"Hematopoietic Cell Growth Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
These growth factors comprise a family of hematopoietic regulators with biological specificities defined by their ability to support proliferation and differentiation of blood cells of different lineages. ERYTHROPOIETIN and the COLONY-STIMULATING FACTORS belong to this family. Some of these factors have been studied and used in the treatment of chemotherapy-induced neutropenia, myelodysplastic syndromes, and bone marrow failure syndromes.
| Descriptor ID |
D016298
|
| MeSH Number(s) |
D12.644.276.374.410 D12.776.467.374.410 D23.529.374.410
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hematopoietic Cell Growth Factors".
Below are MeSH descriptors whose meaning is more specific than "Hematopoietic Cell Growth Factors".
This graph shows the total number of publications written about "Hematopoietic Cell Growth Factors" by people in this website by year, and whether "Hematopoietic Cell Growth Factors" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Hematopoietic Cell Growth Factors" by people in Profiles.
-
Robertson SA, Chin PY, Schjenken JE, Thompson JG. Female tract cytokines and developmental programming in embryos. Adv Exp Med Biol. 2015; 843:173-213.
-
Elias AD. Dose-intensive therapy for small cell lung cancer. Chest. 1995 Jun; 107(6 Suppl):261S-266S.
-
Spritz RA, Ho L, Strunk KM. Inhibition of proliferation of human melanocytes by a KIT antisense oligodeoxynucleotide: implications for human piebaldism and mouse dominant white spotting (W). J Invest Dermatol. 1994 Aug; 103(2):148-50.
-
Schibler KR, Ohls RK, Le T, Liechty KW, Christensen RD. Effect of recombinant stem cell factor on clonogenic maturation and cycle status of human fetal hematopoietic progenitors. Pediatr Res. 1994 Mar; 35(3):303-6.
-
Spritz RA, Holmes SA. Polymerase chain reaction detection of a novel human KIT (mast/stem cell growth factor receptor) gene polymorphism by single-strand conformation polymorphism analysis or by SmaI or BstNI cleavage. Hum Genet. 1993 Sep; 92(2):208-9.
-
Mayordomo JI, Rivera F, Diaz-Puente MT, Lianes P, Cortes-Funes H. Re: Decision analysis of hematopoietic growth factor use in patients receiving cancer chemotherapy. J Natl Cancer Inst. 1993 Aug 04; 85(15):1251-3.
-
Spritz RA, Freedman MH. Lack of mutations of the MGF and KIT genes in Diamond-Blackfan anemia. Blood. 1993 Jun 01; 81(11):3165.
-
Ayash LJ, Elias A, Wheeler C, Tepler I, Schwartz G, Schnipper L, Frei E, Antman K. High-dose chemotherapy with autologous stem cell support for breast cancer: a review of the Dana-Farber Cancer Institute/Beth Israel Hospital experience. J Hematother. 1993; 2(4):507-11.
-
Avraham H, Vannier E, Cowley S, Jiang SX, Chi S, Dinarello CA, Zsebo KM, Groopman JE. Effects of the stem cell factor, c-kit ligand, on human megakaryocytic cells. Blood. 1992 Jan 15; 79(2):365-71.
-
Zucali JR, Broxmeyer HE, Gross MA, Dinarello CA. Recombinant human tumor necrosis factors alpha and beta stimulate fibroblasts to produce hemopoietic growth factors in vitro. J Immunol. 1988 Feb 01; 140(3):840-4.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|